CN111803252A - A kind of stainless steel and its preparation method and drug-eluting stent - Google Patents
A kind of stainless steel and its preparation method and drug-eluting stent Download PDFInfo
- Publication number
- CN111803252A CN111803252A CN202010877513.6A CN202010877513A CN111803252A CN 111803252 A CN111803252 A CN 111803252A CN 202010877513 A CN202010877513 A CN 202010877513A CN 111803252 A CN111803252 A CN 111803252A
- Authority
- CN
- China
- Prior art keywords
- stainless steel
- drug
- electrolyte
- small
- holes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/02—Inorganic materials
- A61L31/022—Metals or alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/146—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25D—PROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
- C25D11/00—Electrolytic coating by surface reaction, i.e. forming conversion layers
- C25D11/02—Anodisation
- C25D11/34—Anodisation of metals or alloys not provided for in groups C25D11/04 - C25D11/32
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/43—Hormones, e.g. dexamethasone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
- A61L2300/604—Biodegradation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- Materials Engineering (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Cardiology (AREA)
- Metallurgy (AREA)
- Organic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Inorganic Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Chemical Treatment Of Metals (AREA)
Abstract
本发明涉及不锈钢技术领域,尤其涉及一种不锈钢及其制备方法和药物洗脱支架。本发明提供的不锈钢表面的大孔和小孔均是原位生成的,与不锈钢结合紧密;不锈钢表面的大孔和小孔均可以加载药物,可达到双载药的目的,而且能够实现药物缓慢释放的效果。本发明提供的不锈钢可以应用在药物洗脱支架中时,大孔可以负载混合药物载体的第一种药物,小孔仅负载第二种药物,大孔中的第一种药物可以随着药物载体的降解逐渐释放,达到缓释的效果,小孔中的第二种药物可以相对第一种药物较快释放缓解支架植入体内初期引发的炎症等反应症状。不锈钢大孔和小孔中的药物能更好的满足支架植入初期和后期对药物的不同需求。
The invention relates to the technical field of stainless steel, in particular to a stainless steel and a preparation method thereof and a drug-eluting stent. The large holes and small holes on the surface of the stainless steel provided by the invention are generated in situ and are closely combined with the stainless steel; both the large holes and the small holes on the surface of the stainless steel can be loaded with drugs, which can achieve the purpose of double drug loading, and can realize slow drug loading. release effect. When the stainless steel provided by the present invention can be used in drug-eluting stents, the large pores can carry the first drug mixed with the drug carrier, the small pores only carry the second drug, and the first drug in the large pores can be loaded with the drug carrier The degradation of the stent is gradually released to achieve the effect of sustained release, and the second drug in the small hole can be released faster than the first drug to relieve the symptoms of inflammation and other reactions caused by the initial implantation of the stent in the body. The drugs in the large and small holes of the stainless steel can better meet the different needs for drugs in the initial and later stages of stent implantation.
Description
技术领域technical field
本发明涉及不锈钢技术领域,尤其涉及一种不锈钢及其制备方法和药物洗脱支架。The invention relates to the technical field of stainless steel, in particular to a stainless steel and a preparation method thereof and a drug-eluting stent.
背景技术Background technique
316L不锈钢由于具有良好的生物相容性、力学性能及耐腐蚀性,而被广泛应用于矫形外科植入物、牙种植体及冠状动脉支架等医学领域。在316L不锈钢表面制备纳米叠孔结构,有利于药物的加载以及达到药物缓释的效果。316L stainless steel is widely used in orthopedic implants, dental implants and coronary stents and other medical fields due to its good biocompatibility, mechanical properties and corrosion resistance. The nano-stacked pore structure is prepared on the surface of 316L stainless steel, which is beneficial to the loading of drugs and the effect of sustained drug release.
药物洗脱支架可以明显地降低血管的再狭窄率。通常采用免疫抑制药雷帕霉素(RAPA)、抗增殖药物紫杉醇(PTX)、抗炎性药物地塞米松(DXM)和抗血栓药物水蛙素(Hirudin)等功能性药物,将药物加载到支架金属基体中,当支架植入体内病变部位后,就达到在局部病变部位进行药物精准释放,达到抑制平滑肌细胞增殖和炎症、血栓发生等的目的。Drug-eluting stents can significantly reduce the rate of vascular restenosis. Functional drugs such as the immunosuppressive drug rapamycin (RAPA), the antiproliferative drug paclitaxel (PTX), the anti-inflammatory drug dexamethasone (DXM), and the antithrombotic drug Hirudin are usually used to load the drug into the In the metal matrix of the stent, when the stent is implanted into the diseased part of the body, it can achieve precise drug release in the local diseased part, and achieve the purpose of inhibiting the proliferation of smooth muscle cells, inflammation, and thrombosis.
现有的技术中,《纳米多孔阳极氧化铝在支架上控释药物》(Kang,HJ,Kim,DJ,Park,SJ,Yoo,JB,Ryu,YS.Controlled drug release using nanoporous anodicaluminum oxide on stent[C]Thin Solid Films 515(2007)5184–5187)在316L不锈钢表面通过涂覆方法使表面存在纳米孔氧化铝层从而达到载药目的,但是药物达不到缓释的效果,而且氧化铝纳米孔层与基体不锈钢之间存在结合力不足,容易使涂层脱落的问题。《使用复合聚乳酸(乳酸-共-乙醇酸)缓释布洛芬/钛植入物表面的二氧化钛纳米管》(Jia,HY,Kerr.LLSustained Ibuprofen Release Using Composite Poly(Lactic-co-GlycolicAcid)/Titanium Dioxide Nanotubes from Ti Implant Surface[J].Journal ofPharmaceutical Sciences,Vol.102,2341–2348(2013))中采用聚合物加载药物,缓释效果好,但存在晚期血栓的问题,而且手术过程中聚合物药物涂层容易剥落。Among the existing technologies, "Controlled drug release using nanoporous anodized aluminum oxide on stent" (Kang, HJ, Kim, DJ, Park, SJ, Yoo, JB, Ryu, YS. Controlled drug release using nanoporous anodicaluminum oxide on stent[ C] Thin Solid Films 515 (2007) 5184–5187) on the surface of 316L stainless steel by coating method to make nanoporous alumina layer on the surface to achieve the purpose of drug loading, but the drug can not achieve the effect of sustained release, and alumina nanoporous There is a problem that the bonding force between the layer and the base stainless steel is insufficient, and the coating is easy to fall off. "Using Composite Polylactic Acid (Lactic-Co-Glycolic Acid) Sustained Release Ibuprofen/Titanium Dioxide Nanotubes on the Surface of Titanium Implants" ( Jia,HY , Kerr.LL Sustained Ibuprofen Release Using Composite Poly(Lactic-co-GlycolicAcid) /Titanium Dioxide Nanotubes from Ti Implant Surface[J].Journal of Pharmaceutical Sciences,Vol.102,2341–2348(2013)) uses polymer loaded drug, the sustained release effect is good, but there is the problem of late thrombosis, and during the operation The polymer drug coating peels off easily.
发明内容SUMMARY OF THE INVENTION
本发明提供了一种不锈钢及其制备方法和药物洗脱支架,解决了药物涂层与基体存在结合力不足,易脱落的问题。The invention provides a stainless steel and a preparation method thereof and a drug-eluting stent, which solve the problems of insufficient binding force between the drug coating and the substrate and easy to fall off.
其具体技术方案如下:Its specific technical solutions are as follows:
本发明提供了一种不锈钢,所述不锈钢表面原位生成小孔和大孔,所述大孔和所述小孔呈大孔套小孔的叠孔结构。The invention provides a kind of stainless steel. Small holes and large holes are formed on the surface of the stainless steel in situ, and the large holes and the small holes are in a stacked hole structure in which the large holes are set over the small holes.
本发明中,不锈钢表面的大孔和小孔均是原位生成,因此,不存在涂层与基体的结合力不足的问题;不锈钢表面大孔和小孔均可以加载药物,实现双载药的效果,而且可达到延长药物释放时间的效果。In the present invention, the large holes and small holes on the surface of the stainless steel are formed in situ, so there is no problem of insufficient bonding force between the coating and the substrate; both the large and small holes on the surface of the stainless steel can be loaded with drugs, so as to realize double drug loading. effect, and can achieve the effect of prolonging the drug release time.
本发明中,所述大孔与所述小孔的孔径比为(18:5)~(15:1),优选为(12:1),其中,小孔的孔径为20nm~50nm,适合小分子药物的负载,大孔的孔径为180nm~300nm,优选为180nm~260nm。In the present invention, the pore size ratio of the large pores to the small pores is (18:5)~(15:1), preferably (12:1), wherein the pore size of the small pores is 20nm~50nm, which is suitable for small pores. For molecular drug loading, the pore size of the macropore is 180nm-300nm, preferably 180nm-260nm.
小孔的深度约为4μm-5μm,大孔的深度约为20nm-45nm。大孔孔径大且具一定孔深,可提高可降解聚合物药物载体与不锈钢之间的结合力。The depth of the small holes is about 4 μm-5 μm, and the depth of the large holes is about 20 nm-45 nm. The macropore has a large pore size and a certain pore depth, which can improve the binding force between the degradable polymer drug carrier and the stainless steel.
本发明中,小孔数量多且孔径合适,因而可以满足临床所需药物的加载量。In the present invention, the number of small pores is large and the pore size is suitable, so that the loading amount of the drug required by the clinic can be satisfied.
本发明中,不锈钢优选为316L不锈钢。In the present invention, the stainless steel is preferably 316L stainless steel.
本发明还提供了一种不锈钢的制备方法,包括以下步骤:The present invention also provides a preparation method of stainless steel, comprising the following steps:
步骤1:以不锈钢作为阳极,石墨作为阴极,在第一电解液中进行第一次阳极氧化,得到表面含大孔结构的不锈钢;Step 1: use stainless steel as the anode and graphite as the cathode, and perform the first anodic oxidation in the first electrolyte to obtain stainless steel with a macroporous structure on the surface;
步骤2:以所述表面含大孔结构的不锈钢作为阳极,石墨作为阴极,在第二电解液中进行第二次阳极氧化,退火处理后,得到大孔套小孔的呈叠孔结构的不锈钢;Step 2: Using the stainless steel with the macroporous structure on the surface as the anode and the graphite as the cathode, the second anodic oxidation is performed in the second electrolyte, and after annealing treatment, the stainless steel with the large pores and the small pores in the stacked pore structure is obtained ;
所述第一电解液为磷酸二氢钠水溶液、磷酸二氢钾水溶液电解质或磷酸水溶液,优选为磷酸二氢钠水溶液;The first electrolyte is sodium dihydrogen phosphate aqueous solution, potassium dihydrogen phosphate aqueous solution electrolyte or phosphoric acid aqueous solution, preferably sodium dihydrogen phosphate aqueous solution;
所述第二电解液为氟化铵的醇溶液。The second electrolyte is an alcoholic solution of ammonium fluoride.
本发明第一次阳极氧化的目的是获得不锈钢表面的大孔,第二次阳极氧化的目的是获得不锈钢表面的小孔,从而获得大孔套小孔的叠孔结构薄膜。The purpose of the first anodic oxidation of the present invention is to obtain large pores on the surface of the stainless steel, and the purpose of the second anodic oxidation is to obtain small pores on the surface of the stainless steel, thereby obtaining a stacked-porous structure film with large pores and small pores.
本发明步骤1中,优选以不锈钢片作为阳极,以石墨片作为阴极。In step 1 of the present invention, preferably a stainless steel sheet is used as the anode, and a graphite sheet is used as the cathode.
所述不锈钢片在进行第一次阳极氧化前,还需进行前处理;The stainless steel sheet needs to be pre-treated before the first anodization;
所述前处理具体包括:将不锈钢依次进行砂纸打磨、清洗、电化学抛光,透明胶封装反应面背面。The pretreatment specifically includes: sandpaper grinding, cleaning, and electrochemical polishing of the stainless steel in sequence, and transparent glue encapsulating the back of the reaction surface.
所述打磨为500#-1500#砂纸逐级打磨;所述清洗为分别在丙酮、乙醇、去离子水下,在超声条件下清洗10min;所述电化学抛光中,抛光液为磷酸和硫酸混合液,体积比为3:2;抛光步骤为不锈钢作为阳极,石墨作为阴极,反应时间为4min-6min,搅拌子转速为760r/min,反应温度为85℃,反应电流密度为30A/dm2-50A/dm2。The grinding is step-by-step grinding with 500#-1500# sandpaper; the cleaning is acetone, ethanol, and deionized water, respectively, under ultrasonic conditions for 10 minutes; in the electrochemical polishing, the polishing solution is a mixture of phosphoric acid and sulfuric acid liquid, the volume ratio is 3:2; in the polishing step, stainless steel is used as the anode, graphite is used as the cathode, the reaction time is 4min-6min, the stirring speed is 760r/min, the reaction temperature is 85℃, and the reaction current density is 30A/dm 2 - 50A/dm 2 .
本发明步骤1中,所述第一电解液的浓度为0.05mol/L-0.4mol/L,优选为0.3mol/L;In step 1 of the present invention, the concentration of the first electrolyte is 0.05mol/L-0.4mol/L, preferably 0.3mol/L;
所述第一次阳极氧化的电压为20V-60V,优选为30V,时间为5min-40min,优选为20min,反应温度为0℃~20℃,优选为0℃,搅拌转速为350r/min。The voltage of the first anodic oxidation is 20V-60V, preferably 30V, the time is 5min-40min, preferably 20min, the reaction temperature is 0°C to 20°C, preferably 0°C, and the stirring speed is 350r/min.
本发明第一次阳极氧化在特定的工艺参数下才能在不锈钢表面原位生成大孔结构。The first anodic oxidation of the present invention can only generate macroporous structure in situ on the stainless steel surface under specific process parameters.
本发明步骤2中,所述第二电解液氟化铵的醇溶液中的溶剂优选为乙二醇,所述氟化铵的醇溶液的浓度为0.05-0.15mol/L,优选为0.15mol/L;In step 2 of the present invention, the solvent in the alcoholic solution of ammonium fluoride of the second electrolyte is preferably ethylene glycol, and the concentration of the alcoholic solution of ammonium fluoride is 0.05-0.15mol/L, preferably 0.15mol/L. L;
所述第二次阳极氧化的电压为40-60V,优选为60V,时间为10min-60min,优选为10min,反应温度为0-35℃,优选为20℃,搅拌转速为600r/min;The voltage of the second anodic oxidation is 40-60V, preferably 60V, the time is 10min-60min, preferably 10min, the reaction temperature is 0-35°C, preferably 20°C, and the stirring speed is 600r/min;
所述退火处理优选在氮气或惰性气体的氛围下进行,所述惰性气体优选为氩气,所述退火温度为350℃~400℃,保温时间为40min~60min,升温时间与降温时间为5℃~6℃/min。The annealing treatment is preferably carried out in an atmosphere of nitrogen or an inert gas, the inert gas is preferably argon, the annealing temperature is 350°C to 400°C, the holding time is 40min to 60min, and the heating time and the cooling time are 5°C ~6°C/min.
本发明第二次阳极氧化在特定的工艺参数下才能在不锈钢表面原位生成小孔结构,进而与大孔形成叠孔结构。The second anodic oxidation of the present invention can only generate a small pore structure on the surface of the stainless steel in situ under specific process parameters, and then form a stacked pore structure with the large pores.
本发明还提供了上述不锈钢或上述制备方法制得的不锈钢在制备药物洗脱支架中的应用。The present invention also provides the application of the above stainless steel or the stainless steel prepared by the above preparation method in the preparation of a drug-eluting stent.
本发明还提供了一种药物洗脱支架,包括:上述不锈钢或上述制备方法制得的不锈钢、加载在所述不锈钢表面大孔中的药物载体和第一种药物,以及加载在所述不锈钢表面小孔内的第二种药物。The present invention also provides a drug-eluting stent, comprising: the above-mentioned stainless steel or the stainless steel prepared by the above-mentioned preparation method, a drug carrier and a first drug loaded in the large pores on the surface of the stainless steel, and a drug loaded on the surface of the stainless steel A second drug in the small hole.
本发明提供的药物洗脱支架中,以不锈钢作为基体,价格低廉。不锈钢大孔中药物载体可以使得第一种药物达到缓释的效果,从而达到最佳的治疗效果。当支架植入体内后,体内会发生炎症等反应,由于小孔中第二种药物未混合药物载体,第二种药物会较快的释放来缓解炎症。药物洗脱支架中两种药物更好的满足支架植入初期和后期对药物的不同需求。In the drug-eluting stent provided by the present invention, stainless steel is used as the matrix, and the price is low. The drug carrier in the large pores of stainless steel can make the first drug achieve the effect of slow release, so as to achieve the best therapeutic effect. When the stent is implanted in the body, reactions such as inflammation will occur in the body. Since the second drug in the small hole is not mixed with a drug carrier, the second drug will be released faster to relieve inflammation. The two drugs in drug-eluting stents better meet the different needs of drugs in the initial and later stages of stent implantation.
本发明中,可降解聚合物优选为壳聚糖或聚乳酸乙醇酸共聚物(PLGA),更优选为PLGA75/25;In the present invention, the degradable polymer is preferably chitosan or poly(lactic-co-glycolic acid) (PLGA), more preferably PLGA75/25;
所述第一种药物为预防血管再狭窄类药物,优选为雷帕霉素和/或紫杉醇;The first drug is a drug for preventing vascular restenosis, preferably rapamycin and/or paclitaxel;
所述第二种药物为抗炎症药物,优选为地塞米松。The second drug is an anti-inflammatory drug, preferably dexamethasone.
本发明中,大孔结构可提高聚合物与支架的结合力,同时降低两种药物的突释,第一种药物可随着可降解聚合物的降解而释放。不锈钢叠孔结构中仅大孔中含聚合物,聚合物用量少,能降低晚期血栓的发生概率。In the present invention, the macroporous structure can improve the binding force between the polymer and the stent, and at the same time reduce the burst release of the two drugs, and the first drug can be released with the degradation of the degradable polymer. In the stacked-hole structure of stainless steel, only the large pores contain polymer, and the amount of polymer is small, which can reduce the probability of late thrombosis.
本发明中,所述第一种药物与所述药物载体的质量比为(2:8)~(4:6),优选为3:7。In the present invention, the mass ratio of the first drug to the drug carrier is (2:8) to (4:6), preferably 3:7.
本发明药物洗脱支架的制备方法,包括以下步骤:The preparation method of the drug-eluting stent of the present invention comprises the following steps:
1)制备第一种药物溶液:将第一种药物与药物载体混合后溶于溶剂中,得到第一种药物溶液;1) prepare the first medicine solution: after the first medicine is mixed with the medicine carrier, it is dissolved in the solvent to obtain the first medicine solution;
2)制备第二种药物溶液:将第二种药物溶于溶剂中,得到第二种药物溶液;2) preparing the second drug solution: dissolving the second drug in the solvent to obtain the second drug solution;
3)采用浸涂法将第二种药物溶液加载到叠孔结构的小孔中,干燥后,继续采用浸涂法将第一种药物溶液加载到叠孔结构的大孔中,干燥,得到药物洗脱支架。3) The second drug solution is loaded into the pores of the stacked pore structure by dip coating method, and after drying, the first drug solution is loaded into the large pores of the stacked pore structure by the dip coating method, and dried to obtain the drug Elution stent.
本发明步骤1)中硅橡胶优选为706硅橡胶。In step 1) of the present invention, the silicone rubber is preferably 706 silicone rubber.
本发明步骤1)中,所述溶剂优选为1,4-二氧六环;所述第一种药物溶液中,所述药物载体的质量浓度为1%~2%,优选为1%。In step 1) of the present invention, the solvent is preferably 1,4-dioxane; in the first drug solution, the mass concentration of the drug carrier is 1% to 2%, preferably 1%.
本发明步骤2)中,所述溶剂优选为乙醇,所述第二种药物溶液的浓度为1mg/mL-2mg/mL,优选为1mg/mL。In step 2) of the present invention, the solvent is preferably ethanol, and the concentration of the second drug solution is 1 mg/mL-2 mg/mL, preferably 1 mg/mL.
本发明步骤3)中,采用浸涂法将第二种药物溶液加载到小孔后,干燥,重复操作,待第二种药物加载量达以预设目标值后,再进行第一种药物溶液的浸涂按预设值浸涂在大孔中,干燥;所述第二种药物溶液的干燥优选在真空干燥箱中37℃下真空干燥1h,所述第一种药物溶液干燥优选在常温中干燥24h,再在干燥箱中于37℃下干燥2h。In step 3) of the present invention, after the second drug solution is loaded into the small hole by dip coating, it is dried, and the operation is repeated. After the loading of the second drug reaches the preset target value, the first drug solution is added. The dipping coating of the second drug solution is dipped in the macropore according to the preset value and dried; the drying of the second drug solution is preferably vacuum drying in a vacuum drying oven at 37 ° C for 1 h, and the drying of the first drug solution is preferably at room temperature. Dry for 24h, and then dry in a drying oven at 37°C for 2h.
从以上技术方案可以看出,本发明具有以下优点:As can be seen from the above technical solutions, the present invention has the following advantages:
本发明提供了一种不锈钢,所述不锈钢表面原位生成小孔和大孔,所述大孔和所述小孔呈大孔套小孔的叠孔结构。The invention provides a kind of stainless steel. Small holes and large holes are formed on the surface of the stainless steel in situ, and the large holes and the small holes are in a stacked hole structure in which the large holes are set over the small holes.
本发明提供的不锈钢表面的大孔和小孔均是原位生成的,与不锈钢结合紧密;不锈钢表面的大孔和小孔均可以加载药物,实现双载药的效果,可达到延长药物的释放时间目的。本发明提供的不锈钢可以应用在药物洗脱支架中时,大孔可以负载混合药物载体的第一种药物,小孔仅负载第二种药物,大孔中的第一种药物可以随着药物载体的降解逐渐释放,达到缓释的效果,小孔中的第二种药物可以相对第一种药物较快释放缓解支架植入体内初期引发的炎症等反应症状。不锈钢大孔和小孔中的药物能更好的满足支架植入初期和后期对药物的不同需求。The large holes and small holes on the surface of the stainless steel provided by the invention are generated in situ, and are closely combined with the stainless steel; both the large holes and the small holes on the surface of the stainless steel can be loaded with drugs, the effect of double drug loading can be realized, and the release of the drugs can be prolonged. time purpose. When the stainless steel provided by the present invention can be used in drug-eluting stents, the large pores can carry the first drug mixed with the drug carrier, the small pores only carry the second drug, and the first drug in the large pores can be loaded with the drug carrier The degradation of the stent is gradually released to achieve the effect of sustained release, and the second drug in the small hole can be released faster than the first drug to relieve the symptoms of inflammation and other reactions caused by the initial implantation of the stent in the body. The drugs in the large and small holes of stainless steel can better meet the different needs of drugs in the early and later stages of stent implantation.
附图说明Description of drawings
为了更清楚地说明本发明实施例或现有技术中的技术方案,下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动性的前提下,还可以根据这些附图获得其它的附图。In order to explain the embodiments of the present invention or the technical solutions in the prior art more clearly, the following briefly introduces the accompanying drawings that need to be used in the description of the embodiments or the prior art. Obviously, the accompanying drawings in the following description are only These are some embodiments of the present invention. For those of ordinary skill in the art, other drawings can also be obtained based on these drawings without any creative effort.
图1为本发明实施例3提供的叠孔结构的不锈钢表面的高倍扫描电镜图;Fig. 1 is the high magnification scanning electron microscope image of the stainless steel surface of the stacked hole structure provided in the embodiment 3 of the present invention;
图2为本发明实施例3提供的叠孔结构的不锈钢表面的低倍扫描电镜图;Fig. 2 is the low magnification scanning electron microscope image of the stainless steel surface of the stacked hole structure provided in Example 3 of the present invention;
图3为本发明实施例3提供的药物洗脱支架的两种药物洗脱释放曲线示意图;3 is a schematic diagram of two drug-eluting release curves of the drug-eluting stent provided in Example 3 of the present invention;
图4为本发明对比例1提供的不锈钢阳极氧化表面的高倍扫描电镜图;Fig. 4 is the high magnification scanning electron microscope picture of the stainless steel anodic oxidation surface that the comparative example 1 of the present invention provides;
图5为本发明对比例2提供的不锈钢阳极氧化表面的低倍扫描电镜图。5 is a low-magnification scanning electron microscope image of the anodized surface of the stainless steel provided in Comparative Example 2 of the present invention.
具体实施方式Detailed ways
为使得本发明的发明目的、特征、优点能够更加的明显和易懂,下面将对本发明实施例中的技术方案进行清楚、完整地描述,显然,下面所描述的实施例仅仅是本发明一部分实施例,而非全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其它实施例,都属于本发明保护的范围。In order to make the purpose, features and advantages of the present invention more obvious and understandable, the technical solutions in the embodiments of the present invention will be clearly and completely described below. Obviously, the embodiments described below are only a part of the implementation of the present invention. examples, but not all examples. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts shall fall within the protection scope of the present invention.
本发明实施例中所述水均为去离子水。The water described in the embodiments of the present invention is deionized water.
实施例1Example 1
本实施例为叠孔结构的不锈钢的制备This example is the preparation of stainless steel with stacked hole structure
阳极氧化工艺:将封装后的不锈钢片作阳极,石墨作阴极(50mm×130mm),极间距为35mm,阴极正对面积大于阳极,利用低温恒温反应浴进行控温,磁力搅拌转速为600r/min,以确保阳极氧化时反应物的传质和扩散均匀。阳极氧化分两步进行。Anodizing process: use the encapsulated stainless steel sheet as the anode, graphite as the cathode (50mm×130mm), the pole spacing is 35mm, the cathode area is larger than that of the anode, and the temperature is controlled by a low-temperature constant temperature reaction bath, and the magnetic stirring speed is 600r/min , to ensure uniform mass transfer and diffusion of reactants during anodization. Anodizing is carried out in two steps.
第一步阳极氧化:电解质采用磷酸二氢钠/水体系,其中磷酸二氢钠的浓度为0.3mol/L,采用恒压法,电压为30V,恒温水浴温度为0℃,调整磁力搅拌转速为350r/min,阳极氧化时间为20min;The first step anodization: the electrolyte adopts sodium dihydrogen phosphate/water system, wherein the concentration of sodium dihydrogen phosphate is 0.3mol/L, the constant pressure method is used, the voltage is 30V, the temperature of the constant temperature water bath is 0℃, and the magnetic stirring speed is adjusted to 350r/min, anodizing time is 20min;
第二步阳极氧化:电解质采用氟化铵/乙二醇有机电解质体系,其中氟化铵的浓度为0.05M,采用恒压法,电压为40V,恒温水浴温度为35℃,阳极氧化时间为10min,调整磁力搅拌转速为600r/min。待两步阳极氧化反应完成后,将所制备的试样置于装有乙醇的小烧杯中保存,并于清洗池中超声清洗10min以去除试样表面的电解液。The second step of anodic oxidation: the electrolyte adopts ammonium fluoride/ethylene glycol organic electrolyte system, in which the concentration of ammonium fluoride is 0.05M, the constant voltage method is used, the voltage is 40V, the temperature of the constant temperature water bath is 35℃, and the anodic oxidation time is 10min , adjust the magnetic stirring speed to 600r/min. After the two-step anodic oxidation reaction was completed, the prepared samples were stored in a small beaker containing ethanol, and ultrasonically cleaned in a cleaning tank for 10 min to remove the electrolyte on the surface of the samples.
将阳极氧化后的试样在氩气的氛围下,进行退火处理,退火温度为350℃,保温时间为40min,升温时间与降温时间为5℃/min,得到叠孔结构的不锈钢。The anodized sample was annealed in an argon atmosphere. The annealing temperature was 350 °C, the holding time was 40 min, and the heating time and cooling time were 5 °C/min to obtain a stainless steel with a stacked-hole structure.
微观形貌观察:使用场发射扫描电子显微镜(日立SU8010)对试样表面形貌进行观察,不锈钢表面大孔呈不规则多边型,大孔内部的小孔呈类蜂窝状且孔径达20nm-60nm,整体规则且整洁,呈类网状结构。Microscopic morphology observation: The surface morphology of the sample was observed using a field emission scanning electron microscope (Hitachi SU8010). The macropores on the stainless steel surface were irregular polygonal, and the small pores inside the macropores were honeycomb-like and the pore size was 20nm-60nm. , the overall regular and neat, a network-like structure.
实施例2Example 2
本实施例为叠孔结构的不锈钢的制备This example is the preparation of stainless steel with stacked hole structure
阳极氧化工艺:将封装后的不锈钢片作阳极,石墨作阴极(50mm×130mm),极间距为35mm,阴极正对面积大于阳极,利用低温恒温反应浴进行控温,磁力搅拌转速为600r/min,以确保阳极氧化时反应物的传质和扩散均匀。阳极氧化分两步进行。Anodizing process: use the encapsulated stainless steel sheet as the anode, graphite as the cathode (50mm×130mm), the pole spacing is 35mm, the cathode area is larger than that of the anode, and the temperature is controlled by a low-temperature constant temperature reaction bath, and the magnetic stirring speed is 600r/min , to ensure uniform mass transfer and diffusion of reactants during anodization. Anodizing is carried out in two steps.
第一步阳极氧化:电解质采用磷酸二氢钠/水体系,其中磷酸二氢钠的浓度为0.3mol/L,采用恒压法,电压为30V,恒温水浴温度为0℃,调整磁力搅拌转速为350r/min,阳极氧化时间为20min;The first step anodization: the electrolyte adopts sodium dihydrogen phosphate/water system, wherein the concentration of sodium dihydrogen phosphate is 0.3mol/L, the constant pressure method is used, the voltage is 30V, the temperature of the constant temperature water bath is 0℃, and the magnetic stirring speed is adjusted to 350r/min, anodizing time is 20min;
第二步阳极氧化:电解质采用氟化铵/乙二醇有机电解质体系,其中氟化铵的浓度为0.10M,采用恒压法,电压为40V,恒温水浴温度为0℃,阳极氧化时间为60min,调整磁力搅拌转速为600r/min。待两步阳极氧化反应完成后,将所制备的试样置于装有乙醇的小烧杯中保存,并于清洗池中超声清洗10min以去除试样表面的电解液。The second step of anodic oxidation: the electrolyte adopts ammonium fluoride/ethylene glycol organic electrolyte system, in which the concentration of ammonium fluoride is 0.10M, the constant voltage method is used, the voltage is 40V, the temperature of the constant temperature water bath is 0℃, and the anodic oxidation time is 60min , adjust the magnetic stirring speed to 600r/min. After the two-step anodic oxidation reaction was completed, the prepared samples were stored in a small beaker containing ethanol, and ultrasonically cleaned in a cleaning tank for 10 min to remove the electrolyte on the surface of the samples.
将阳极氧化后的试样在氩气的氛围下,进行退火处理,退火温度为350℃,保温时间为40min,升温时间与降温时间为5℃/min,得到叠孔结构的不锈钢。The anodized sample was annealed in an argon atmosphere. The annealing temperature was 350 °C, the holding time was 40 min, and the heating time and cooling time were 5 °C/min to obtain a stainless steel with a stacked-hole structure.
微观形貌观察:使用场发射扫描电子显微镜(日立SU8010)对试样表面形貌进行观察,不锈钢表面大孔呈类椭圆型,大孔内部的小孔呈较规整的蜂窝状且孔径达20nm-50nm,整体规则且整洁,类网状结构。Microscopic morphology observation: The surface morphology of the sample was observed using a field emission scanning electron microscope (Hitachi SU8010). 50nm, the overall regular and neat, like a network structure.
实施例3Example 3
本实施例为不锈钢叠孔结构的制备This example is the preparation of stainless steel stacked hole structure
阳极氧化工艺:将封装后的不锈钢片作阳极,石墨作阴极(50mm×130mm),极间距为35mm,阴极正对面积大于阳极,利用低温恒温反应浴进行控温,磁力搅拌转速为600r/min,以确保阳极氧化时反应物的传质和扩散均匀。阳极氧化分两步进行。Anodizing process: use the encapsulated stainless steel sheet as the anode, graphite as the cathode (50mm×130mm), the pole spacing is 35mm, the cathode area is larger than that of the anode, and the temperature is controlled by a low-temperature constant temperature reaction bath, and the magnetic stirring speed is 600r/min , to ensure uniform mass transfer and diffusion of reactants during anodization. Anodizing is carried out in two steps.
第一步阳极氧化:电解质采用磷酸二氢钠/水体系,其中磷酸二氢钠的浓度为0.3mol/L,采用恒压法,电压为30V,恒温水浴温度为0℃,调整磁力搅拌转速为350r/min,阳极氧化时间为20min;The first step anodization: the electrolyte adopts sodium dihydrogen phosphate/water system, wherein the concentration of sodium dihydrogen phosphate is 0.3mol/L, the constant pressure method is used, the voltage is 30V, the temperature of the constant temperature water bath is 0℃, and the magnetic stirring speed is adjusted to 350r/min, anodizing time is 20min;
第二步阳极氧化:电解质采用氟化铵/乙二醇有机电解质体系,其中氟化铵的浓度为0.15M,采用恒压法,电压为60V,恒温水浴温度为20℃,阳极氧化时间为10min,调整磁力搅拌转速为600r/min。待两步阳极氧化反应完成后,将所制备的试样置于装有乙醇的小烧杯中保存,并于清洗池中超声清洗10min以去除试样表面的电解液。The second step of anodic oxidation: the electrolyte adopts ammonium fluoride/ethylene glycol organic electrolyte system, in which the concentration of ammonium fluoride is 0.15M, the constant voltage method is used, the voltage is 60V, the temperature of the constant temperature water bath is 20℃, and the anodic oxidation time is 10min , adjust the magnetic stirring speed to 600r/min. After the two-step anodic oxidation reaction was completed, the prepared samples were stored in a small beaker containing ethanol, and ultrasonically cleaned in a cleaning tank for 10 min to remove the electrolyte on the surface of the samples.
将阳极氧化后的试样进行退火处理,在氩气的氛围下进行,所述退火温度为350℃,保温时间为40min,升温时间与降温时间为5℃/min,得到叠孔结构的不锈钢。The anodized sample was annealed in an argon atmosphere. The annealing temperature was 350°C, the holding time was 40min, and the heating time and cooling time were 5°C/min to obtain a stainless steel with a stacked hole structure.
微观形貌观察:使用场发射扫描电子显微镜(日立SU8010)对试样表面形貌进行观察。如图1和图2所示,不锈钢表面大孔呈类椭圆型,大孔内部的小孔呈较规整的蜂窝状且孔径达30nm-50nm,整体规则,呈类网状结构。Microscopic morphology observation: The surface morphology of the samples was observed using a field emission scanning electron microscope (Hitachi SU8010). As shown in Figure 1 and Figure 2, the large pores on the surface of the stainless steel are elliptical, and the small pores inside the large pores are relatively regular honeycombs with a diameter of 30nm-50nm.
实施例4Example 4
本实施例为叠孔结构的不锈钢的制备This example is the preparation of stainless steel with stacked hole structure
阳极氧化工艺:将封装后的不锈钢片作阳极,石墨作阴极(50mm×130mm),极间距为35mm,阴极正对面积大于阳极,利用低温恒温反应浴进行控温,磁力搅拌转速为600r/min,以确保阳极氧化时反应物的传质和扩散均匀。阳极氧化分两步进行。Anodizing process: use the encapsulated stainless steel sheet as the anode, graphite as the cathode (50mm×130mm), the pole spacing is 35mm, the cathode area is larger than that of the anode, and the temperature is controlled by a low-temperature constant temperature reaction bath, and the magnetic stirring speed is 600r/min , to ensure uniform mass transfer and diffusion of reactants during anodization. Anodizing is carried out in two steps.
第一步阳极氧化:电解质采用磷酸二氢钠/水体系,其中磷酸二氢钠的浓度为0.3mol/L,采用恒压法,电压为30V,恒温水浴温度为0℃,调整磁力搅拌转速为350r/min,阳极氧化时间为20min;The first step anodization: the electrolyte adopts sodium dihydrogen phosphate/water system, wherein the concentration of sodium dihydrogen phosphate is 0.3mol/L, the constant pressure method is used, the voltage is 30V, the temperature of the constant temperature water bath is 0℃, and the magnetic stirring speed is adjusted to 350r/min, anodizing time is 20min;
第二步阳极氧化:电解质采用氟化铵/乙二醇有机电解质体系,其中氟化铵的浓度为0.10M,采用恒压法,电压为40V,恒温水浴温度为35℃,阳极氧化时间为10min,调整磁力搅拌转速为600r/min。待两步阳极氧化反应完成后,将所制备的试样置于装有乙醇的小烧杯中保存,并于清洗池中超声清洗10min以去除试样表面的电解液。The second step of anodic oxidation: the electrolyte adopts ammonium fluoride/ethylene glycol organic electrolyte system, in which the concentration of ammonium fluoride is 0.10M, the constant voltage method is used, the voltage is 40V, the temperature of the constant temperature water bath is 35℃, and the anodic oxidation time is 10min , adjust the magnetic stirring speed to 600r/min. After the two-step anodic oxidation reaction was completed, the prepared samples were stored in a small beaker containing ethanol, and ultrasonically cleaned in a cleaning tank for 10 min to remove the electrolyte on the surface of the samples.
将阳极氧化后的试样进行退火处理,在氩气的氛围下进行,所述退火温度为350℃,保温时间为40min,升温时间与降温时间为5℃/min,得到叠孔结构的不锈钢。The anodized sample was annealed in an argon atmosphere. The annealing temperature was 350°C, the holding time was 40min, and the heating time and cooling time were 5°C/min to obtain a stainless steel with a stacked hole structure.
微观形貌观察:使用场发射扫描电子显微镜(日立SU8010)对试样表面形貌进行观察,不锈钢表面大孔呈不规则型,大孔内部的小孔多有相连,表面整洁规则,呈类网状结构。Microscopic morphology observation: The surface morphology of the sample was observed using a field emission scanning electron microscope (Hitachi SU8010). The large pores on the surface of the stainless steel were irregular, and the small pores inside the large pores were mostly connected. like structure.
实施例5Example 5
本实施例为叠孔结构的不锈钢的制备This example is the preparation of stainless steel with stacked hole structure
阳极氧化工艺:将封装后的不锈钢片作阳极,石墨作阴极(50mm×130mm),极间距为35mm,阴极正对面积大于阳极,利用低温恒温反应浴进行控温,磁力搅拌转速为600r/min,以确保阳极氧化时反应物的传质和扩散均匀。阳极氧化分两步进行。Anodizing process: use the encapsulated stainless steel sheet as the anode, graphite as the cathode (50mm×130mm), the pole spacing is 35mm, the cathode area is larger than that of the anode, and the temperature is controlled by a low-temperature constant temperature reaction bath, and the magnetic stirring speed is 600r/min , to ensure uniform mass transfer and diffusion of reactants during anodization. Anodizing is carried out in two steps.
第一步阳极氧化:电解质采用磷酸二氢钠/水体系,其中磷酸二氢钠的浓度为0.3mol/L,采用恒压法,电压为30V,恒温水浴温度为0℃,调整磁力搅拌转速为350r/min,阳极氧化时间为20min;The first step anodization: the electrolyte adopts sodium dihydrogen phosphate/water system, wherein the concentration of sodium dihydrogen phosphate is 0.3mol/L, the constant pressure method is used, the voltage is 30V, the temperature of the constant temperature water bath is 0℃, and the magnetic stirring speed is adjusted to 350r/min, anodizing time is 20min;
第二步阳极氧化:电解质采用氟化铵/乙二醇有机电解质体系,其中氟化铵的浓度为0.05M,采用恒压法,电压为40V,恒温水浴温度为35℃,阳极氧化时间为15min,调整磁力搅拌转速为600r/min。待两步阳极氧化反应完成后,将所制备的试样置于装有乙醇的小烧杯中保存,并于清洗池中超声清洗10min以去除试样表面的电解液。The second step of anodic oxidation: the electrolyte adopts ammonium fluoride/ethylene glycol organic electrolyte system, in which the concentration of ammonium fluoride is 0.05M, the constant voltage method is used, the voltage is 40V, the temperature of the constant temperature water bath is 35℃, and the anodic oxidation time is 15min , adjust the magnetic stirring speed to 600r/min. After the two-step anodic oxidation reaction was completed, the prepared samples were stored in a small beaker containing ethanol, and ultrasonically cleaned in a cleaning tank for 10 min to remove the electrolyte on the surface of the samples.
将阳极氧化后的试样进行退火处理,在氩气的氛围下进行,所述退火温度为350℃,保温时间为40min,升温时间与降温时间为5℃/min,得到叠孔结构的不锈钢。The anodized sample was annealed in an argon atmosphere. The annealing temperature was 350°C, the holding time was 40min, and the heating time and cooling time were 5°C/min to obtain a stainless steel with a stacked hole structure.
微观形貌观察:使用场发射扫描电子显微镜(日立SU8010)对试样表面形貌进行观察,不锈钢表面大孔呈不规则多边型,大孔内部的小孔呈类蜂窝状且有部分小孔相互连接,整体规则且整洁,呈类网状结构。Microscopic morphology observation: The surface morphology of the sample was observed using a field emission scanning electron microscope (Hitachi SU8010). The large pores on the surface of the stainless steel were irregular polygonal, and the small pores inside the large pores were honeycomb-like and some small pores were interconnected. Connections, the overall regularity and cleanliness, in a network-like structure.
实施例6Example 6
药物洗脱支架的制备,具体包括以下步骤:The preparation of the drug-eluting stent specifically includes the following steps:
1)使用10mm×10mm正方形706硅橡胶在实施例3不锈钢叠孔结构表面圈出10mm×10mm正方形状固定面积,待硅橡胶干燥后备用。1) Use a 10mm×10mm square 706 silicone rubber to circle a 10mm×10mm square fixed area on the surface of the stainless steel stacked hole structure of Example 3, and wait for the silicone rubber to dry for later use.
2)制备雷帕霉素溶液:将雷帕霉素与可降解聚合物PLGA70/25按质量比为3:7混合后,按终浓度为1wt%的可降解聚合物溶于1,4-二氧六环中,缓慢搅拌,得到雷帕霉素溶液;2) Preparation of rapamycin solution: after mixing rapamycin and degradable polymer PLGA70/25 in a mass ratio of 3:7, the degradable polymer with a final concentration of 1 wt % is dissolved in 1,4-diol. In oxane, slowly stir to obtain rapamycin solution;
3)制备地塞米松溶液:将地塞米松溶于乙醇中,缓慢搅拌,得到1mg/mL地塞米松溶液;3) Preparation of dexamethasone solution: dissolve dexamethasone in ethanol and stir slowly to obtain 1 mg/mL dexamethasone solution;
4)采用浸涂法将地塞米松溶液加载到硅橡胶所围面积处的小孔中,37℃下真空干燥1h,待地塞米松加载值为100μg时,继续采用浸涂法将第一种药物溶液加载到硅橡胶所围面积处的大孔中,待雷帕霉素值为150μg时,在常温中干燥24h,再在真空干燥箱中于37℃下干燥2h,得到药物洗脱支架。4) Use the dip coating method to load the dexamethasone solution into the small holes in the area surrounded by the silicone rubber, and vacuum dry it at 37°C for 1 hour. When the dexamethasone loading value is 100 μg, continue to use the dip coating method to apply the first type of dexamethasone solution. The drug solution was loaded into the large pores in the area surrounded by the silicone rubber, and when the rapamycin value was 150 μg, it was dried at room temperature for 24 hours, and then dried in a vacuum drying oven at 37°C for 2 hours to obtain a drug-eluting stent.
分步释放工艺:将载药后的试样置于装有磷酸盐缓冲液中(PBS)的离心管中,然后在恒温培养箱中进行药物释放研究,培养温度37℃,分步释放时间间隔为1h、1h、2h、3h、12h、24h、24h、77h、97h、168h、168h,每次更换等量新的PBS溶液时,需将原来离心管中的PBS溶液保留以作检测,检测通过紫外分光光度计(UV)完成。如图3所示,地塞米松和雷帕霉素各自的缓释效果良好,药物能够持续释放三周以上。Step-by-step release process: The drug-loaded samples were placed in a centrifuge tube filled with phosphate buffered saline (PBS), and then the drug release study was carried out in a constant temperature incubator at a culture temperature of 37°C and a step-by-step release time interval. For 1h, 1h, 2h, 3h, 12h, 24h, 24h, 77h, 97h, 168h, 168h, each time an equal amount of new PBS solution is replaced, the PBS solution in the original centrifuge tube needs to be retained for detection. Ultraviolet spectrophotometer (UV) completed. As shown in Figure 3, the sustained-release effects of dexamethasone and rapamycin are good, and the drugs can be continuously released for more than three weeks.
对比例1Comparative Example 1
本对比例1为不锈钢的制备This comparative example 1 is the preparation of stainless steel
阳极氧化工艺:将封装后的不锈钢片作阳极,石墨作阴极(50mm×130mm),极间距为35mm,阴极正对面积大于阳极,利用低温恒温反应浴进行控温,磁力搅拌转速为600r/min,以确保阳极氧化时反应物的传质和扩散均匀。阳极氧化分两步进行。Anodizing process: use the encapsulated stainless steel sheet as the anode, graphite as the cathode (50mm×130mm), the pole spacing is 35mm, the cathode area is larger than that of the anode, and the temperature is controlled by a low-temperature constant temperature reaction bath, and the magnetic stirring speed is 600r/min , to ensure uniform mass transfer and diffusion of reactants during anodization. Anodizing is carried out in two steps.
第一步阳极氧化:电解质采用磷酸二氢钠/水体系,其中磷酸二氢钠的浓度为0.3mol/L,采用恒压法,电压为30V,恒温水浴温度为0℃,调整磁力搅拌转速为350r/min,阳极氧化时间为20min;The first step anodization: the electrolyte adopts sodium dihydrogen phosphate/water system, wherein the concentration of sodium dihydrogen phosphate is 0.3mol/L, the constant pressure method is used, the voltage is 30V, the temperature of the constant temperature water bath is 0℃, and the magnetic stirring speed is adjusted to 350r/min, anodizing time is 20min;
第二步阳极氧化:电解质采用氟化铵/乙二醇有机电解质体系,其中氟化铵的浓度为0.15M,采用恒压法,电压为40V,恒温水浴温度为35℃,阳极氧化时间为15min,调整磁力搅拌转速为600r/min。待两步阳极氧化反应完成后,将所制备的试样置于装有乙醇的小烧杯中保存,并于清洗池中超声清洗10min以去除试样表面的电解液。The second step of anodic oxidation: the electrolyte adopts ammonium fluoride/ethylene glycol organic electrolyte system, in which the concentration of ammonium fluoride is 0.15M, the constant voltage method is used, the voltage is 40V, the temperature of the constant temperature water bath is 35℃, and the anodic oxidation time is 15min , adjust the magnetic stirring speed to 600r/min. After the two-step anodic oxidation reaction was completed, the prepared samples were stored in a small beaker containing ethanol, and ultrasonically cleaned in a cleaning tank for 10 min to remove the electrolyte on the surface of the samples.
将阳极氧化后的试样在氩气的氛围下,进行退火处理,退火温度为350℃,保温时间为40min,升温时间与降温时间为5℃/min,得到不锈钢。The anodized sample was annealed in an argon atmosphere, the annealing temperature was 350 °C, the holding time was 40 min, and the heating time and cooling time were 5 °C/min to obtain stainless steel.
本对比例较实施例1第二步阳极氧化的电解液浓度升高,阳极氧化时间增加,从而导致不锈钢表面腐蚀过度,大孔结构被完全腐蚀掉,小孔结构也不够规整。Compared with Example 1, the concentration of the electrolyte in the second step of anodic oxidation in this comparative example increases, and the anodic oxidation time increases, which leads to excessive corrosion of the stainless steel surface, the macroporous structure is completely corroded, and the small pore structure is not regular enough.
对比例2Comparative Example 2
本对比例2为不锈钢的制备This comparative example 2 is the preparation of stainless steel
阳极氧化工艺:将封装后的不锈钢片作阳极,石墨作阴极(50mm×130mm),极间距为35mm,阴极正对面积大于阳极,利用低温恒温反应浴进行控温,磁力搅拌转速为600r/min,以确保阳极氧化时反应物的传质和扩散均匀。阳极氧化分两步进行。Anodizing process: use the encapsulated stainless steel sheet as the anode, graphite as the cathode (50mm×130mm), the pole spacing is 35mm, the cathode area is larger than that of the anode, and the temperature is controlled by a low-temperature constant temperature reaction bath, and the magnetic stirring speed is 600r/min , to ensure uniform mass transfer and diffusion of reactants during anodization. Anodizing is carried out in two steps.
第一步阳极氧化:电解质采用磷酸二氢钠/水(文中提到的水均为去离子水)体系,其中磷酸二氢钠的浓度为0.3mol/L,采用恒压法,电压为30V,恒温水浴温度为0℃,调整磁力搅拌转速为350r/min,阳极氧化时间为20min;The first step of anodic oxidation: the electrolyte adopts sodium dihydrogen phosphate/water (the water mentioned in the text is deionized water) system, wherein the concentration of sodium dihydrogen phosphate is 0.3mol/L, the constant voltage method is adopted, and the voltage is 30V, The temperature of the constant temperature water bath is 0°C, the magnetic stirring speed is adjusted to 350r/min, and the anodizing time is 20min;
第二步阳极氧化:电解质采用氟化铵/乙二醇有机电解质体系,其中氟化铵的浓度为0.15M,采用恒压法,电压为40V,恒温水浴温度为20℃,阳极氧化时间为10min,调整磁力搅拌转速为600r/min。待两步阳极氧化反应完成后,将所制备的试样置于装有乙醇的小烧杯中保存,并于清洗池中超声清洗10min以去除试样表面的电解液。The second step of anodic oxidation: the electrolyte adopts ammonium fluoride/ethylene glycol organic electrolyte system, in which the concentration of ammonium fluoride is 0.15M, the constant voltage method is used, the voltage is 40V, the temperature of the constant temperature water bath is 20℃, and the anodic oxidation time is 10min , adjust the magnetic stirring speed to 600r/min. After the two-step anodic oxidation reaction was completed, the prepared samples were stored in a small beaker containing ethanol, and ultrasonically cleaned in a cleaning tank for 10 min to remove the electrolyte on the surface of the samples.
将阳极氧化后的试样在氩气的氛围下,进行退火处理,退火温度为350℃,保温时间为40min,升温时间与降温时间为5℃/min,得到不锈钢。The anodized sample was annealed in an argon atmosphere, the annealing temperature was 350 °C, the holding time was 40 min, and the heating time and cooling time were 5 °C/min to obtain stainless steel.
本对比例较实施例3降低了反应电压的值,导致生成的小孔结构不够规整,孔径大小不一。Compared with Example 3, this comparative example lowers the value of the reaction voltage, resulting in that the structure of the generated pores is not regular enough, and the pore sizes are different.
以上所述,以上实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的精神和范围。As mentioned above, the above embodiments are only used to illustrate the technical solutions of the present invention, but not to limit them; although the present invention has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art should understand: The technical solutions described in the embodiments are modified, or some technical features thereof are equivalently replaced; and these modifications or replacements do not make the essence of the corresponding technical solutions depart from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010877513.6A CN111803252B (en) | 2020-08-27 | 2020-08-27 | Stainless steel, preparation method thereof and drug eluting stent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010877513.6A CN111803252B (en) | 2020-08-27 | 2020-08-27 | Stainless steel, preparation method thereof and drug eluting stent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111803252A true CN111803252A (en) | 2020-10-23 |
| CN111803252B CN111803252B (en) | 2023-11-14 |
Family
ID=72859886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010877513.6A Active CN111803252B (en) | 2020-08-27 | 2020-08-27 | Stainless steel, preparation method thereof and drug eluting stent |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111803252B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110904489A (en) * | 2019-12-03 | 2020-03-24 | 天津理工大学 | Micro-arc oxidation electrolyte for preparing high-corrosion-resistance coating on surface of low-carbon steel and preparation method and application thereof |
| CN112386377A (en) * | 2020-11-30 | 2021-02-23 | 山东瑞安泰医疗技术有限公司 | Medicine-carrying type punctiform stent |
| CN114032595A (en) * | 2021-12-01 | 2022-02-11 | 成都飞机工业(集团)有限责任公司 | Preparation method of micro-nano holes on surface of nickel-containing iron-chromium alloy |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070259101A1 (en) * | 2006-05-02 | 2007-11-08 | Kleiner Lothar W | Microporous coating on medical devices |
| CN101437467A (en) * | 2004-08-13 | 2009-05-20 | 斯特根有限公司 | Medical devices having porous layers and methods for making the same |
| CN101785880A (en) * | 2009-12-31 | 2010-07-28 | 东南大学 | Blood vessel bracket utilizing titanium oxide nanotube to load medicine |
| CN101874907A (en) * | 2009-04-30 | 2010-11-03 | 科迪斯公司 | Dual drug stent |
| US20140072608A1 (en) * | 2012-08-30 | 2014-03-13 | Stergios Logothetidis | Method for production of nanoporous multi-layer biodegradable polymeric coatings and products thereof |
| CN104562052A (en) * | 2014-12-23 | 2015-04-29 | 广东工业大学 | Method for preparing ordered micropore structure on stainless steel surface |
| CN105483799A (en) * | 2015-12-13 | 2016-04-13 | 华北电力大学(保定) | Preparation method of micropore structure on surface of stainless steel |
| CN106467939A (en) * | 2015-08-19 | 2017-03-01 | 重庆润泽医药有限公司 | A kind of multi-stage porous metal fabrication methods |
| CN107620105A (en) * | 2017-10-24 | 2018-01-23 | 内蒙古科技大学 | Nanoscale pitch of holes anodic oxidation aluminium formwork and preparation method thereof |
| CN108404228A (en) * | 2018-03-14 | 2018-08-17 | 广东工业大学 | A kind of preparation method of stainless steel nano drug-carrying holder and slow-releasing agent |
-
2020
- 2020-08-27 CN CN202010877513.6A patent/CN111803252B/en active Active
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101437467A (en) * | 2004-08-13 | 2009-05-20 | 斯特根有限公司 | Medical devices having porous layers and methods for making the same |
| US20070259101A1 (en) * | 2006-05-02 | 2007-11-08 | Kleiner Lothar W | Microporous coating on medical devices |
| CN101874907A (en) * | 2009-04-30 | 2010-11-03 | 科迪斯公司 | Dual drug stent |
| CN101785880A (en) * | 2009-12-31 | 2010-07-28 | 东南大学 | Blood vessel bracket utilizing titanium oxide nanotube to load medicine |
| US20140072608A1 (en) * | 2012-08-30 | 2014-03-13 | Stergios Logothetidis | Method for production of nanoporous multi-layer biodegradable polymeric coatings and products thereof |
| CN104562052A (en) * | 2014-12-23 | 2015-04-29 | 广东工业大学 | Method for preparing ordered micropore structure on stainless steel surface |
| CN106467939A (en) * | 2015-08-19 | 2017-03-01 | 重庆润泽医药有限公司 | A kind of multi-stage porous metal fabrication methods |
| CN105483799A (en) * | 2015-12-13 | 2016-04-13 | 华北电力大学(保定) | Preparation method of micropore structure on surface of stainless steel |
| CN107620105A (en) * | 2017-10-24 | 2018-01-23 | 内蒙古科技大学 | Nanoscale pitch of holes anodic oxidation aluminium formwork and preparation method thereof |
| CN108404228A (en) * | 2018-03-14 | 2018-08-17 | 广东工业大学 | A kind of preparation method of stainless steel nano drug-carrying holder and slow-releasing agent |
Non-Patent Citations (2)
| Title |
|---|
| 皮立波: "316L不锈钢表面微孔结构制备及载药性能研究", 《中国优秀硕士学位论文全文数据库工程科技I辑》 * |
| 皮立波: "316L不锈钢表面微孔结构制备及载药性能研究", 《中国优秀硕士学位论文全文数据库工程科技I辑》, 15 February 2020 (2020-02-15), pages 6 - 58 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110904489A (en) * | 2019-12-03 | 2020-03-24 | 天津理工大学 | Micro-arc oxidation electrolyte for preparing high-corrosion-resistance coating on surface of low-carbon steel and preparation method and application thereof |
| CN112386377A (en) * | 2020-11-30 | 2021-02-23 | 山东瑞安泰医疗技术有限公司 | Medicine-carrying type punctiform stent |
| CN114032595A (en) * | 2021-12-01 | 2022-02-11 | 成都飞机工业(集团)有限责任公司 | Preparation method of micro-nano holes on surface of nickel-containing iron-chromium alloy |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111803252B (en) | 2023-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111803252A (en) | A kind of stainless steel and its preparation method and drug-eluting stent | |
| CN101785880B (en) | Drug-loaded vascular stents using titanium oxide nanotubes | |
| CN105177670B (en) | Method for in-situ growth of nanotubes on the surface of titanium-based materials with three-dimensional porous structure | |
| KR101281722B1 (en) | A manufacturing method for enhancing biomolecule loading property implant materials by using porous titania layer and Implant materials fabricated there by | |
| CN103611188B (en) | Preparation method of tissue suitable type composite material dental implant | |
| CN101161299A (en) | Hole and polymer-loaded drug release structure and preparation method thereof | |
| KR100947094B1 (en) | Medical Stent and Method of Manufacturing the Same | |
| CN103469284A (en) | Preparation method of carbon nanotube/titania nanotube bio-composite coat material | |
| WO2023151343A1 (en) | Degradable biomedical magnesium alloy drug-eluting vascular stent and preparation method | |
| CN106267342A (en) | A kind of dentistry implant and preparation method thereof | |
| CN1569270A (en) | Method for preparing cardiovascular drug eluting stent | |
| CN113181438B (en) | A heat-responsive absorbable orthopedic device material capable of self-healing and promoting bone growth and preparation method thereof | |
| CN104193889A (en) | Preparation of photosensitive copolymer self-assembling micelle and medical nano-coating of photosensitive copolymer self-assembling micelle | |
| CN110639056A (en) | Preparation method of medical magnesium alloy surface drug release functional coating | |
| CN200980748Y (en) | Porous drug release structure of a drug eluting device | |
| CN115444971A (en) | A comprehensive processing method for biodegradable porous magnesium alloy scaffold for bone defect repair | |
| CN111603615B (en) | Controllable degradable high-strength magnesium-based composite stent composite coating and preparation method thereof | |
| CN108404228A (en) | A kind of preparation method of stainless steel nano drug-carrying holder and slow-releasing agent | |
| CN101607097B (en) | Biological polypeptide medical device and manufacturing method thereof | |
| EP4129351A1 (en) | Method for production of nanostructured surfaces on stents for improved biocompatibility | |
| CN115554466A (en) | Titanium metal implant drug release system and preparation method and application thereof | |
| CN103469279B (en) | The dexamethasone TLM titanium alloy drug stent preparation method of non-polymer carrier | |
| CN101491468B (en) | Preparation method of gene coatings of medical device | |
| CN117100916B (en) | Degradable flexible devices for regulating the degradation of medical magnesium alloys | |
| CN105797207A (en) | Drug release carrier on metal substrate and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |